The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

by Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ
Published 2019-07-01

UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma

by Liu LL, Zhu JM, Yu XN, Zhu HR, Shi X, Bilegsaikhan E, Guo HY, Wu J, Shen XZ
Published 2019-09-01

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study

by Chen H, Zhu HR, Yu XN, Shi X, Bilegsaikhan E, Guo HY, Huang RZ, Liu TT, Shen XZ, Zhu JM
Published 2019-04-01